Abstract
Patients with Myasthenia Gravis (MG) experience severe functional impairment. This study assessed the disease burden, treatment landscape and health-related quality of life (HRQoL) in patients with MG.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have